
Will GoodRX Stock Bounce Back?
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Date | Quarter | Revenue Forecast | Actual Revenue | Reported EPS | Consensus EPS | Beat/Miss |
---|---|---|---|---|---|---|
12/31/2024 | Q4 | -- | $6.3M | -$23.13 | -- | -- |
11/20/2024 | Q3 | -- | $6.2M | -$0.34 | -- | -- |
07/24/2024 | Q2 | -- | $12.7M | -$10.01 | -- | -- |
05/09/2024 | Q1 | -- | $13.4M | -$5.59 | -- | -- |
03/28/2024 | Q4 | -- | $20.5M | -$23.34 | -- | -- |
10/26/2023 | Q3 | -- | $13.7M | -$18.02 | -- | -- |
09/08/2023 | Q2 | -- | $6.9M | -$17.12 | -- | -- |
06/16/2023 | Q1 | -- | $5.3M | -$5.84 | -- | -- |
12/31/2022 | Q4 | -- | $4.1M | -$6.75 | -- | -- |
09/30/2022 | Q3 | -- | $3.9M | -$5.84 | -- | -- |
08/22/2022 | Q2 | -- | $3.3M | -$38.73 | -- | -- |
03/31/2022 | Q1 | -- | $2.3M | -$5.84 | -- | -- |
06/30/2021 | Q2 | -- | $512.8K | -$6.42 | -- | -- |
Naas Technology reported $6.3M worth of top line sales in its most recent quarter.
Naas Technology announced earnings per share of -$23.13 which represents a miss of analyst forecast a -- per share.
Naas Technology reported $3.5M that represents $0.26 per share over the last quarter.
Naas Technology's earnings are forecast to decrease from -$39.02 per share to -$0.60 per share next year representing a decrease of -99.31%.
Naas Technology's next earnings date is July 24, 2025.
Signup to receive the latest stock alerts
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Freeport-McMoRan (NYSE:FCX) is among the world’s largest producers of copper…
Levi Strauss (NYSE:LEVI) is among the oldest clothing brands in…
Market Cap: $4.2T
P/E Ratio: 58x
Market Cap: $3.8T
P/E Ratio: 43x
Market Cap: $3.1T
P/E Ratio: 35x
SharpLink Gaming [SBET] is down 2.6% over the past day.
Exodus Movement [EXOD] is down 4.14% over the past day.
Unity Software [U] is up 7.51% over the past day.